Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Decoding apoptosis, ferroptosis, and inflammatory cell death in adenomyosis at single-cell resolution.

Created on 18 Jul 2026

Authors

Qingjing Sheng, Qiongwei Wu, Jiao Fan, Vinoth Kumar Sangaraju, Balachandran Manavalan, Xiaoying He

Published in

Briefings in bioinformatics. Volume 27. Issue 4. Jul 03, 2026.

Abstract

Accurate pathway activity inference from single-cell RNA sequencing (scRNA-seq) data is hindered by sparsity, technical noise, and the weak yet coordinated nature of transcriptional programs. Existing methods typically aggregate expression values over predefined gene sets, which can obscure context-dependent regulatory structure. Here, we present Graph-based Pathway Activity Scoring (GraphPAS), a hierarchical graph learning framework for recovering coherent pathway-level structure from scRNA-seq data. Systematic benchmarking across scRNA-seq datasets showed that GraphPAS consistently achieved higher adjusted Rand index, normalized mutual information, and silhouette width than AUCell and scapGNN, while maintaining greater robustness under dropout and Gaussian noise perturbations. Applied to adenomyosis scRNA-seq data, GraphPAS revealed enrichment of programmed cell death programs in macrophages. Pain-associated samples showed elevated apoptosis, ferroptosis, and necroptosis signatures accompanied by inflammatory activation, implicating macrophage-centered cell death remodeling in the adenomyosis microenvironment.

PMID:
42467989
Bibliographic data and abstract were imported from PubMed on 18 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement